Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2016

Dec 20, 2016

30198_dirs_2016-12-20_22cead51-776e-46ec-b3fd-ceef7f2c3ca7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-12-09

Reporting Person: Murphy Patrick Michael (VP, Legal Aff & Chf Compl Ofcr)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 29128 Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of DexCom, Inc. common stock.

F2: Included in this number are 29,128 unvested restricted stock units, 15,000 of which were granted on March 8, 2016 and shall vest 5,000 restricted stock units on March 8, 2017 and the remaining 10,000 restricted stock units shall vest over four equal installments on September 8, 2017, March 8, 2018, September 8, 2018 and March 8, 2019, 8,462 of which were granted on March 8, 2015 and 4,231 restricted stock units shall vest on each of March 8, 2017 and March 8, 2018, and 5,666 of which were granted on March 8, 2014 and shall vest on March 8, 2017.